Skip to content

Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell Carcinoma

Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06111560
Enrollment
160
Registered
2023-11-01
Start date
2012-02-01
Completion date
2022-02-01
Last updated
2023-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma, Renal Cell

Brief summary

Patients with renal cell carcinoma who were admitted to the First Affiliated Hospital of Sun Yat-sen University from February 1, 2021, to February 1, 2022, and met the following inclusion and exclusion criteria were collected. Clinical factors influencing the prognosis of enrolled patients were retrospectively analyzed, and a predictive system was established based on this. (Inclusion criteria: pathology of the surgical specimen confirmed the diagnosis of pRCC,b: age 18 years or older, c: localized RCC underwent radical nephrectomy or partial nephrectomy in our center. Exclusion criteria:a: lack of original CT images, b: patients with malignant tumors of other systems, c: patients who lost follow-up.)

Interventions

OTHERWe do not have any interventions. This study is based on obseravation.

observational retrospective study without any interventions

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

a: pathology of the surgical specimen confirmed the diagnosis of pRCC,b: age 18 years or older, c: localized RCC underwent radical nephrectomy or partial nephrectomy in our center

Exclusion criteria

a: lack of original CT images, b: patients with malignant tumors of other systems, c: patients who lost follow-up

Design outcomes

Primary

MeasureTime frameDescription
Tumor progression12 monthsmedical imaging examinations showed tumor progression

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026